Core C: Sphingolipid Cancer Animal Pathology Core

核心 C:鞘脂癌症动物病理学核心

基本信息

  • 批准号:
    10020946
  • 负责人:
  • 金额:
    $ 21.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The overall objective of the Sphingolipid Animal Cancer Pathobiology (SACP) Shared Resource is to provide the Project leaders of this Program Project with the knowledge, resources and ability to fully and efficiently utilize animal models in the execution of their research projects and to advance their preclinical studies. Through the SACP core, the projects utilize genetically engineered mouse models (GEMM) for the investigation of the mechanisms involved in carcinogenesis and metastasis, specifically utilizing a unique set of animals with deletions in genes of sphingolipid metabolism coupled with pathologically-relevant animal models of specific cancers. Indeed, the SACP has become a national repository for sphingolipid knock out mice, having generated several of them. Preclinical models, specifically animal models, of cancer are invaluable tools for the identification and validation of novel functions, interventions, therapeutic targets, and biomarkers. Therefore, the Core will provide the projects with “start-to-finish” expertise in utilizing in vivo models in their research projects. The Core will assist with i) animal model selection; ii) generation of animal models of carcinogenesis, including the generation of novel GEMM; iii) development and use of patient-derived xenografts (PDXs) and engraftment of human cells in vivo; iv) BioBanking of samples for future and/or collaborative studies; and v) access and use of critical relevant shared resources available throught the Cancer Center and/or University. The SACP Core will provide the framework for the projects to efficiently and effectively conduct in vivo resarch. To this end the SACP Core will: Specific Aim 1: Provide investigators with the necessary resources to implement in vivo models of cancer; Specific Aim 2: Enable the execution of preclinical and translational models in carcinogenesis, as well as BioBanking of samples; and Specific Aim 3: Advance the impact of in vivo research through the use of Shared Resources, animal model alternatives, and data management. The services and expertise of the SACP Core will facilitate in vivo research outlined in this proposal and will provide the expertise to support the Project Leaders. With the incorporation of carcinogenesis models and GEMM in sphingolipids, this Core is evolving as a unique and enabling Core that is critical for the success of the Program Projects and their advancement to preclinical studies.
摘要 鞘脂动物癌症病理学(SACP)共享资源的总体目标是提供 本计划项目的项目负责人,具备充分有效利用知识、资源和能力 在执行研究项目时使用动物模型,并推进临床前研究。通过 SACP的核心,该项目利用基因工程小鼠模型(GEMM)的调查, 涉及致癌和转移的机制,特别是利用一组独特的动物, 鞘脂代谢基因的缺失与特异性的病理相关动物模型相结合, 癌的事实上,SACP已经成为鞘脂敲除小鼠的国家储存库, 其中几个 癌症的临床前模型,特别是动物模型,是鉴定和治疗癌症的宝贵工具。 新功能、干预、治疗靶点和生物标志物的验证。因此,核心将提供 在研究项目中利用体内模型方面具有“从头到尾”的专业知识的项目。芯会 协助i)动物模型选择; ii)致癌作用动物模型的生成,包括生成 iii)患者来源的异种移植物(PDX)的开发和使用以及人细胞的植入 体内; iv)用于未来和/或合作研究的样本生物银行;以及v)关键相关 癌症中心和/或大学附近的共享资源。SACP核心将提供 该框架的项目,以有效地进行体内研究。 具体目标1:为调查人员提供必要的资源, 实现癌症的体内模型;具体目标2:能够执行临床前和转化 具体目标3:提高对环境的影响, 通过使用共享资源,动物模型替代品和数据进行体内研究 管理 SACP核心的服务和专业知识将促进本提案中概述的体内研究,并将 提供专业知识以支持项目负责人。随着致癌模型的引入, GEMM在鞘脂中的应用,这一核心正在发展成为一个独特的和使能的核心,这是成功的关键, 计划项目及其临床前研究进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ashley J. Snider其他文献

Ashley J. Snider的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ashley J. Snider', 18)}}的其他基金

Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
  • 批准号:
    10418031
  • 财政年份:
    2022
  • 资助金额:
    $ 21.8万
  • 项目类别:
Role for myeloid acid ceramidase in colon inflammation and cancer
髓样酸性神经酰胺酶在结肠炎症和癌症中的作用
  • 批准号:
    10593982
  • 财政年份:
    2022
  • 资助金额:
    $ 21.8万
  • 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
  • 批准号:
    10338567
  • 财政年份:
    2021
  • 资助金额:
    $ 21.8万
  • 项目类别:
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
鞘脂、膳食脂肪酸和肠道病理生理学
  • 批准号:
    10532716
  • 财政年份:
    2021
  • 资助金额:
    $ 21.8万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    9975866
  • 财政年份:
    2020
  • 资助金额:
    $ 21.8万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    10133427
  • 财政年份:
    2020
  • 资助金额:
    $ 21.8万
  • 项目类别:
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
开发动物模型以将溶酶体与酸性鞘磷脂酶的炎症功能分离
  • 批准号:
    9806440
  • 财政年份:
    2019
  • 资助金额:
    $ 21.8万
  • 项目类别:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
SC COBRE:动物病理学核心
  • 批准号:
    8360379
  • 财政年份:
    2011
  • 资助金额:
    $ 21.8万
  • 项目类别:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
SC COBRE:动物病理学核心
  • 批准号:
    8168044
  • 财政年份:
    2010
  • 资助金额:
    $ 21.8万
  • 项目类别:
The Role of Sphingolipids in Inflammatory Bowel Disease
鞘脂在炎症性肠病中的作用
  • 批准号:
    7749790
  • 财政年份:
    2009
  • 资助金额:
    $ 21.8万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 21.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了